{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:25Z","timestamp":1791295705019,"version":"4.1.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T00:00:00Z","timestamp":1461369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["083810\/Z\/07\/Z"],"award-info":[{"award-number":["083810\/Z\/07\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Seventh Framework Programme","award":["HIVINNOV 305137"],"award-info":[{"award-number":["HIVINNOV 305137"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP1DA034990"],"award-info":[{"award-number":["DP1DA034990"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI087390"],"award-info":[{"award-number":["R01 AI087390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI102824"],"award-info":[{"award-number":["R21 AI102824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56 AI108432"],"award-info":[{"award-number":["R56 AI108432"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"Francis Crick Institute","doi-asserted-by":"publisher","award":["DS_10178.NMR"],"award-info":[{"award-number":["DS_10178.NMR"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of education Republic of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12977-016-0262-0","type":"journal-article","created":{"date-parts":[[2016,4,23]],"date-time":"2016-04-23T11:58:39Z","timestamp":1461412719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["HIV-1 capsid is involved in post-nuclear entry steps"],"prefix":"10.1186","volume":"13","author":[{"given":"Nan-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Gane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Opp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nicastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Zufferey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Buffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Luban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Selwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Diaz-Griffero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariberto","family":"Fassati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,23]]},"reference":[{"key":"262_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1742-4690-7-96","volume":"7","author":"N Arhel","year":"2010","unstructured":"Arhel N. Revisiting HIV-1 uncoating. Retrovirology. 2010;7:96.","journal-title":"Retrovirology"},{"key":"262_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-4690-3-74","volume":"3","author":"A Fassati","year":"2006","unstructured":"Fassati A. HIV infection of non-dividing cells: a divisive problem. Retrovirology. 2006;3:74.","journal-title":"Retrovirology"},{"key":"262_CR3","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.1128\/JVI.76.11.5667-5677.2002","volume":"76","author":"BM Forshey","year":"2002","unstructured":"Forshey BM, von Schwedler U, Sundquist WI, Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J Virol. 2002;76:5667\u201377.","journal-title":"J Virol"},{"key":"262_CR4","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1128\/JVI.00429-09","volume":"83","author":"V Arfi","year":"2009","unstructured":"Arfi V, Lienard J, Nguyen XN, Berger G, Rigal D, Darlix JL, Cimarelli A. Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. J Virol. 2009;83:7524\u201335.","journal-title":"J Virol"},{"key":"262_CR5","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.1073\/pnas.1014522108","volume":"108","author":"AE Hulme","year":"2011","unstructured":"Hulme AE, Perez O, Hope TJ. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci USA. 2011;108:9975\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR6","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1371\/journal.ppat.0030156","volume":"3","author":"M Yamashita","year":"2007","unstructured":"Yamashita M, Perez O, Hope TJ, Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog. 2007;3:1502\u201310.","journal-title":"PLoS Pathog"},{"key":"262_CR7","doi-asserted-by":"publisher","first-page":"13613","DOI":"10.1128\/JVI.02219-14","volume":"88","author":"Z Lukic","year":"2014","unstructured":"Lukic Z, Dharan A, Fricke T, Diaz-Griffero F, Campbell EM. HIV-1 uncoating is facilitated by dynein and kinesin-1. J Virol. 2014;88:13613\u201325.","journal-title":"J Virol"},{"key":"262_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1742-4690-10-70","volume":"10","author":"H Xu","year":"2013","unstructured":"Xu H, Franks T, Gibson G, Huber K, Rahm N, De Castillia CS, Luban J, Aiken C, Watkins S, Sluis-Cremer N, Ambrose Z. Evidence for biphasic uncoating during HIV-1 infection from a novel imaging assay. Retrovirology. 2013;10:70.","journal-title":"Retrovirology"},{"key":"262_CR9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1128\/JVI.05811-11","volume":"86","author":"A Roa","year":"2012","unstructured":"Roa A, Hayashi F, Yang Y, Lienlaf M, Zhou J, Shi J, Watanabe S, Kigawa T, Yokoyama S, Aiken C, Diaz-Griffero F. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J Virol. 2012;86:1717\u201327.","journal-title":"J Virol"},{"key":"262_CR10","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.3390\/v6114195","volume":"6","author":"P Pawlica","year":"2014","unstructured":"Pawlica P, Berthoux L. Cytoplasmic dynein promotes HIV-1 uncoating. Viruses. 2014;6:4195\u2013211.","journal-title":"Viruses"},{"key":"262_CR11","doi-asserted-by":"publisher","first-page":"9835","DOI":"10.1128\/JVI.01084-09","volume":"83","author":"M Yamashita","year":"2009","unstructured":"Yamashita M, Emerman M. Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells. J Virol. 2009;83:9835\u201343.","journal-title":"J Virol"},{"key":"262_CR12","doi-asserted-by":"publisher","first-page":"12001","DOI":"10.1128\/JVI.01518-08","volume":"82","author":"M Qi","year":"2008","unstructured":"Qi M, Yang R, Aiken C. Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells. J Virol. 2008;82:12001\u20138.","journal-title":"J Virol"},{"key":"262_CR13","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1128\/JVI.80.8.3712-3720.2006","volume":"80","author":"DJ Dismuke","year":"2006","unstructured":"Dismuke DJ, Aiken C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J Virol. 2006;80:3712\u201320.","journal-title":"J Virol"},{"key":"262_CR14","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1128\/JVI.03239-12","volume":"87","author":"C Tipper","year":"2013","unstructured":"Tipper C, Sodroski J. Enhanced autointegration in hyperstable simian immunodeficiency virus capsid mutants blocked after reverse transcription. J Virol. 2013;87:3628\u201339.","journal-title":"J Virol"},{"key":"262_CR15","doi-asserted-by":"publisher","first-page":"e1002439","DOI":"10.1371\/journal.ppat.1002439","volume":"7","author":"T Schaller","year":"2011","unstructured":"Schaller T, Ocwieja KE, Rasaiyaah J, Price AJ, Brady TL, Roth SL, Hue S, Fletcher AJ, Lee K, KewalRamani VN, Noursadeghi M, Jenner RG, James LC, Bushman FD, Towers GJ. HIV-1 capsid\u2013cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011;7:e1002439.","journal-title":"PLoS Pathog"},{"key":"262_CR16","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1371\/journal.ppat.0020060","volume":"2","author":"MK Lewinski","year":"2006","unstructured":"Lewinski MK, Yamashita M, Emerman M, Ciuffi A, Marshall H, Crawford G, Collins F, Shinn P, Leipzig J, Hannenhalli S, Berry CC, Ecker JR, Bushman FD. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2006;2:e60.","journal-title":"PLoS Pathog"},{"key":"262_CR17","doi-asserted-by":"publisher","first-page":"e1002896","DOI":"10.1371\/journal.ppat.1002896","volume":"8","author":"AJ Price","year":"2012","unstructured":"Price AJ, Fletcher AJ, Schaller T, Elliott T, Lee K, Kewalramani VN, Chin JW, Towers GJ, James LC. CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog. 2012;8:e1002896.","journal-title":"PLoS Pathog"},{"key":"262_CR18","doi-asserted-by":"publisher","first-page":"e1004459","DOI":"10.1371\/journal.ppat.1004459","volume":"10","author":"AJ Price","year":"2014","unstructured":"Price AJ, Jacques DA, McEwan WA, Fletcher AJ, Essig S, Chin JW, Halambage UD, Aiken C, James LC. Host cofactors and pharmacologic ligands share an essential interface in HIV-1 capsid that is lost upon disassembly. PLoS Pathog. 2014;10:e1004459.","journal-title":"PLoS Pathog"},{"key":"262_CR19","doi-asserted-by":"publisher","first-page":"e1003693","DOI":"10.1371\/journal.ppat.1003693","volume":"9","author":"KA Matreyek","year":"2013","unstructured":"Matreyek KA, Yucel SS, Li X, Engelman A. Nucleoporin NUP153 phenylalanine-glycine motifs engage a common binding pocket within the HIV-1 capsid protein to mediate lentiviral infectivity. PLoS Pathog. 2013;9:e1003693.","journal-title":"PLoS Pathog"},{"key":"262_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.chom.2010.02.007","volume":"7","author":"K Lee","year":"2010","unstructured":"Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe. 2010;7:221\u201333.","journal-title":"Cell Host Microbe"},{"key":"262_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4690-10-20","volume":"10","author":"A De Iaco","year":"2013","unstructured":"De Iaco A, Santoni F, Vannier A, Guipponi M, Antonarakis S, Luban J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology. 2013;10:20.","journal-title":"Retrovirology"},{"key":"262_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virol.2013.02.008","volume":"440","author":"F Di Nunzio","year":"2013","unstructured":"Di Nunzio F, Fricke T, Miccio A, Valle-Casuso JC, Perez P, Souque P, Rizzi E, Severgnini M, Mavilio F, Charneau P, Diaz-Griffero F. Nup153 and Nup98 bind the HIV-1 core and contribute to the early steps of HIV-1 replication. Virology. 2013;440:8\u201318.","journal-title":"Virology"},{"key":"262_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-4690-10-46","volume":"10","author":"T Fricke","year":"2013","unstructured":"Fricke T, Valle-Casuso JC, White TE, Brandariz-Nunez A, Bosche WJ, Reszka N, Gorelick R, Diaz-Griffero F. The ability of TNPO3-depleted cells to inhibit HIV-1 infection requires CPSF6. Retrovirology. 2013;10:46.","journal-title":"Retrovirology"},{"key":"262_CR24","doi-asserted-by":"publisher","first-page":"e1002194","DOI":"10.1371\/journal.ppat.1002194","volume":"7","author":"L Zhou","year":"2011","unstructured":"Zhou L, Sokolskaja E, Jolly C, James W, Cowley SA, Fassati A. Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathog. 2011;7:e1002194.","journal-title":"PLoS Pathog"},{"key":"262_CR25","first-page":"e04114","volume":"3","author":"K Peng","year":"2014","unstructured":"Peng K, Muranyi W, Glass B, Laketa V, Yant SR, Tsai L, Cihlar T, Muller B, Krausslich HG. Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsid. Life. 2014;3:e04114.","journal-title":"Life"},{"key":"262_CR26","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1128\/JVI.00476-15","volume":"89","author":"AE Hulme","year":"2015","unstructured":"Hulme AE, Kelley Z, Foley D, Hope TJ. Complementary assays reveal a low level of CA associated with viral complexes in the nuclei of HIV-1-infected cells. J Virol. 2015;89:5350\u201361.","journal-title":"J Virol"},{"key":"262_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2015.10.036","volume":"13","author":"CR Chin","year":"2015","unstructured":"Chin CR, Perreira JM, Savidis G, Portmann JM, Aker AM, Feeley EM, Smith MC, Brass AL. Direct visualization of HIV-1 replication intermediates shows that capsid and CPSF6 modulate HIV-1 intra-nuclear invasion and integration. Cell Rep. 2015;13:1717\u201331.","journal-title":"Cell Rep"},{"key":"262_CR28","doi-asserted-by":"publisher","first-page":"18625","DOI":"10.1073\/pnas.1419945112","volume":"111","author":"A Bhattacharya","year":"2014","unstructured":"Bhattacharya A, Alam SL, Fricke T, Zadrozny K, Sedzicki J, Taylor AB, Demeler B, Pornillos O, Ganser-Pornillos BK, Diaz-Griffero F, Ivanov DN, Yeager M. Structural basis of HIV-1 capsid recognition by PF74 and CPSF6. Proc Natl Acad Sci USA. 2014;111:18625\u201330.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1742-4690-10-81","volume":"10","author":"K Bichel","year":"2013","unstructured":"Bichel K, Price AJ, Schaller T, Towers GJ, Freund SM, James LC. HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology. 2013;10:81.","journal-title":"Retrovirology"},{"key":"262_CR30","doi-asserted-by":"publisher","first-page":"e46037","DOI":"10.1371\/journal.pone.0046037","volume":"7","author":"F Di Nunzio","year":"2012","unstructured":"Di Nunzio F, Danckaert A, Fricke T, Perez P, Fernandez J, Perret E, Roux P, Shorte S, Charneau P, Diaz-Griffero F, Arhel NJ. Human nucleoporins promote HIV-1 docking at the nuclear pore, nuclear import and integration. PLoS ONE. 2012;7:e46037.","journal-title":"PLoS ONE"},{"key":"262_CR31","doi-asserted-by":"publisher","first-page":"e1003969","DOI":"10.1371\/journal.ppat.1003969","volume":"10","author":"AM Meehan","year":"2014","unstructured":"Meehan AM, Saenz DT, Guevera R, Morrison JH, Peretz M, Fadel HJ, Hamada M, van Deursen J, Poeschla EM. A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog. 2014;10:e1003969.","journal-title":"PLoS Pathog"},{"key":"262_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cub.2008.07.079","volume":"18","author":"F Christ","year":"2008","unstructured":"Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, Arosio D, Emiliani S, Rain JC, Benarous R, Cereseto A, Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr Biol. 2008;18:1192\u2013202.","journal-title":"Curr Biol"},{"key":"262_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/JVI.01899-09","volume":"84","author":"L Krishnan","year":"2010","unstructured":"Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J Virol. 2010;84:397\u2013406.","journal-title":"J Virol"},{"key":"262_CR34","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.1152725","volume":"319","author":"AL Brass","year":"2008","unstructured":"Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science. 2008;319:921\u20136.","journal-title":"Science"},{"key":"262_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-4690-8-98","volume":"8","author":"A De Iaco","year":"2011","unstructured":"De Iaco A, Luban J. Inhibition of HIV-1 infection by TNPO3 depletion is determined by capsid and detectable after viral cDNA enters the nucleus. Retrovirology. 2011;8:98.","journal-title":"Retrovirology"},{"key":"262_CR36","doi-asserted-by":"publisher","first-page":"e1005050","DOI":"10.1371\/journal.ppat.1005050","volume":"11","author":"M Pizzato","year":"2015","unstructured":"Pizzato M, McCauley SM, Neagu MR, Pertel T, Firrito C, Ziglio S, Dauphin A, Zufferey M, Berthoux L, Luban J. Lv4 is a capsid-specific antiviral activity in human blood cells that restricts viruses of the SIVMAC\/SIVSM\/HIV-2 lineage prior to integration. PLoS Pathog. 2015;11:e1005050.","journal-title":"PLoS Pathog"},{"key":"262_CR37","doi-asserted-by":"publisher","first-page":"E1054","DOI":"10.1073\/pnas.1524213113","volume":"113","author":"GA Sowd","year":"2016","unstructured":"Sowd GA, Serrao E, Wang H, Wang W, Fadel HJ, Poeschla EM, Engelman AN. A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin. Proc Natl Acad Sci USA. 2016;113:E1054\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"262_CR38","doi-asserted-by":"publisher","first-page":"39314","DOI":"10.1074\/jbc.M110.155275","volume":"285","author":"L Vozzolo","year":"2010","unstructured":"Vozzolo L, Loh B, Gane PJ, Tribak M, Zhou L, Anderson I, Nyakatura E, Jenner RG, Selwood D, Fassati A. Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. J Biol Chem. 2010;285:39314\u201328.","journal-title":"J Biol Chem"},{"key":"262_CR39","doi-asserted-by":"publisher","first-page":"e1001220","DOI":"10.1371\/journal.ppat.1001220","volume":"6","author":"WS Blair","year":"2010","unstructured":"Blair WS, Pickford C, Irving SL, Brown DG, Anderson M, Bazin R, Cao J, Ciaramella G, Isaacson J, Jackson L, Hunt R, Kjerrstrom A, Nieman JA, Patick AK, Perros M, Scott AD, Whitby K, Wu H, Butler SL. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 2010;6:e1001220.","journal-title":"PLoS Pathog"},{"key":"262_CR40","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1128\/AAC.00985-13","volume":"57","author":"L Lamorte","year":"2013","unstructured":"Lamorte L, Titolo S, Lemke CT, Goudreau N, Mercier JF, Wardrop E, Shah VB, von Schwedler UK, Langelier C, Banik SS, Aiken C, Sundquist WI, Mason SW. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Antimicrob Agents Chemother. 2013;57:4622\u201331.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jmb.2007.07.070","volume":"373","author":"BN Kelly","year":"2007","unstructured":"Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. J Mol Biol. 2007;373:355\u201366.","journal-title":"J Mol Biol"},{"key":"262_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0022-2836(03)00289-4","volume":"327","author":"C Tang","year":"2003","unstructured":"Tang C, Loeliger E, Kinde I, Kyere S, Mayo K, Barklis E, Sun Y, Huang M, Summers MF. Antiviral inhibition of the HIV-1 capsid protein. J Mol Biol. 2003;327:1013\u201320.","journal-title":"J Mol Biol"},{"key":"262_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bmc.2010.11.045","volume":"19","author":"F Curreli","year":"2011","unstructured":"Curreli F, Zhang H, Zhang X, Pyatkin I, Victor Z, Altieri A, Debnath AK. Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Bioorg Med Chem. 2011;19:77\u201390.","journal-title":"Bioorg Med Chem"},{"key":"262_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nsmb967","volume":"12","author":"F Ternois","year":"2005","unstructured":"Ternois F, Sticht J, Duquerroy S, Krausslich HG, Rey FA. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nat Struct Mol Biol. 2005;12:678\u201382.","journal-title":"Nat Struct Mol Biol"},{"key":"262_CR45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1128\/AAC.02574-15","volume":"60","author":"S Thenin-Houssier","year":"2016","unstructured":"Thenin-Houssier S, de Vera IM, Pedro-Rosa L, Brady A, Richard A, Konnick B, Opp S, Buffone C, Fuhrmann J, Kota S, Billack B, Pietka-Ottlik M, Tellinghuisen T, Choe H, Spicer T, Scampavia L, Diaz-Griffero F, Kojetin DJ, Valente ST. Ebselen, a small molecule capsid-inhibitor of HIV-1 replication. Antimicrob Agents Chemother. 2016;60:2195\u2013208.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR46","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1128\/JVI.01406-10","volume":"85","author":"J Shi","year":"2011","unstructured":"Shi J, Zhou J, Shah VB, Aiken C, Whitby K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J Virol. 2011;85:542\u20139.","journal-title":"J Virol"},{"key":"262_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12977-014-0120-x","volume":"11","author":"T Fricke","year":"2014","unstructured":"Fricke T, Buffone C, Opp S, Valle-Casuso J, Diaz-Griffero F. BI-2 destabilizes HIV-1 cores during infection and prevents binding of CPSF6 to the HIV-1 Capsid. Retrovirology. 2014;11:120.","journal-title":"Retrovirology"},{"key":"262_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/jps.2600590306","volume":"59","author":"SA Kaplan","year":"1970","unstructured":"Kaplan SA. Pharmacokinetic profile of coumermycin A. J Pharm Sci. 1970;59:309\u201313.","journal-title":"J Pharm Sci"},{"key":"262_CR49","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1128\/JVI.76.8.3739-3747.2002","volume":"76","author":"SL Butler","year":"2002","unstructured":"Butler SL, Johnson EP, Bushman FD. Human Immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol. 2002;76:3739\u201347.","journal-title":"J Virol"},{"key":"262_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1742-4690-6-11","volume":"6","author":"L Zaitseva","year":"2009","unstructured":"Zaitseva L, Cherepanov P, Leyens L, Wilson SJ, Rasaiyaah J, Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology. 2009;6:11.","journal-title":"Retrovirology"},{"key":"262_CR51","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0960-9822(02)00952-1","volume":"12","author":"C Pannecouque","year":"2002","unstructured":"Pannecouque C, Pluymers W, Van Maele B, Tetz V, Cherepanov P, De Clercq E, Witvrouw M, Debyser Z. New class of HIV integrase inhibitors that block viral replication in cell culture. Current biology : CB. 2002;12:1169\u201377.","journal-title":"Current biology : CB"},{"key":"262_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1146\/annurev.pharmtox.011008.145553","volume":"49","author":"D Hazuda","year":"2009","unstructured":"Hazuda D, Iwamoto M, Wenning L. Emerging pharmacology: inhibitors of human immunodeficiency virus integration. Annu Rev Pharmacol Toxicol. 2009;49:377\u201394.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"262_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.aaa5936","volume":"349","author":"AT Gres","year":"2015","unstructured":"Gres AT, Kirby KA, KewalRamani VN, Tanner JJ, Pornillos O, Sarafianos SG. STRUCTURAL VIROLOGY. X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability. Science. 2015;349:99\u2013103.","journal-title":"Science"},{"key":"262_CR54","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.2174\/156802608786786624","volume":"8","author":"S Vilar","year":"2008","unstructured":"Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Curr Top Med Chem. 2008;8:1555\u201372","journal-title":"Curr Top Med Chem"},{"key":"262_CR55","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature09640","volume":"469","author":"O Pornillos","year":"2011","unstructured":"Pornillos O, Ganser-Pornillos BK, Yeager M. Atomic-level modelling of the HIV capsid. Nature. 2011;469:424\u20137.","journal-title":"Nature"},{"key":"262_CR56","doi-asserted-by":"publisher","first-page":"15567","DOI":"10.1128\/JVI.79.24.15567-15572.2005","volume":"79","author":"D Perez-Caballero","year":"2005","unstructured":"Perez-Caballero D, Hatziioannou T, Zhang F, Cowan S, Bieniasz PD. Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol. 2005;79:15567\u201372.","journal-title":"J Virol"},{"key":"262_CR57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1128\/JVI.03043-14","volume":"89","author":"AE Hulme","year":"2005","unstructured":"Hulme AE, Kelley Z, Okocha Z, Hope TJ. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells. J Virol. 2015;89:643\u201351.","journal-title":"J Virol"},{"key":"262_CR58","doi-asserted-by":"crossref","unstructured":"Sayah DM, Sokolskaja E, Berthoux L, Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature. 2004;430:569\u201373.","DOI":"10.1038\/nature02777"},{"key":"262_CR59","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1128\/JVI.00713-13","volume":"87","author":"J Shi","year":"2013","unstructured":"Shi J, Friedman DB, Aiken C. Retrovirus restriction by TRIM5 proteins requires recognition of only a small fraction of viral capsid subunits. J Virol. 2013;87:9271\u20138.","journal-title":"J Virol"},{"key":"262_CR60","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI39354","volume":"119","author":"MR Neagu","year":"2009","unstructured":"Neagu MR, Ziegler P, Pertel T, Strambio-De-Castillia C, Grutter C, Martinetti G, Mazzucchelli L, Grutter M, Manz MG, Luban J. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. J Clin Investig. 2009;119:3035\u201347.","journal-title":"J Clin Investig"},{"key":"262_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0092-8674(93)90047-T","volume":"72","author":"J Sukegawa","year":"1993","unstructured":"Sukegawa J, Blobel G. A nuclear pore complex protein that contains zinc finger motifs, binds DNA, and faces the nucleoplasm. Cell. 1993;72:29\u201338.","journal-title":"Cell"},{"key":"262_CR62","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1083\/jcb.123.6.1333","volume":"123","author":"VC Cordes","year":"1993","unstructured":"Cordes VC, Reidenbach S, Kohler A, Stuurman N, van Driel R, Franke WW. Intranuclear filaments containing a nuclear pore complex protein. J Cell Biol. 1993;123:1333\u201344.","journal-title":"J Cell Biol"},{"key":"262_CR63","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1093\/emboj\/20.20.5703","volume":"20","author":"TC Walther","year":"2001","unstructured":"Walther TC, Fornerod M, Pickersgill H, Goldberg M, Allen TD, Mattaj IW. The nucleoporin Nup153 is required for nuclear pore basket formation, nuclear pore complex anchoring and import of a subset of nuclear proteins. The EMBO J. 2001;20:5703\u201314.","journal-title":"The EMBO J"},{"key":"262_CR64","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.126.3.603","volume":"126","author":"N Pante","year":"1994","unstructured":"Pante N, Bastos R, McMorrow I, Burke B, Aebi U. Interactions and three-dimensional localization of a group of nuclear pore complex proteins. J Cell Biol. 1994;126:603\u201317.","journal-title":"J Cell Biol"},{"key":"262_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1083\/jcb.141.1.31","volume":"141","author":"S Shah","year":"1998","unstructured":"Shah S, Tugendreich S, Forbes D. Major binding sites for the nuclear import receptor are the internal nucleoporin Nup153 and the adjacent nuclear filament protein Tpr. J Cell Biol. 1998;141:31\u201349.","journal-title":"J Cell Biol"},{"key":"262_CR66","doi-asserted-by":"publisher","first-page":"38515","DOI":"10.1074\/jbc.M112.378893","volume":"287","author":"M Makise","year":"2012","unstructured":"Makise M, Mackay DR, Elgort S, Shankaran SS, Adam SA, Ullman KS. The Nup153-Nup50 protein interface and its role in nuclear import. J Biol Chem. 2012;287:38515\u201322.","journal-title":"J Biol Chem"},{"key":"262_CR67","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1091\/mbc.E02-09-0620","volume":"14","author":"ME Hase","year":"2003","unstructured":"Hase ME, Cordes VC. Direct interaction with nup153 mediates binding of Tpr to the periphery of the nuclear pore complex. Mol Biol Cell. 2003;14:1923\u201340.","journal-title":"Mol Biol Cell"},{"key":"262_CR68","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jmb.2005.06.034","volume":"351","author":"SM Paulillo","year":"2005","unstructured":"Paulillo SM, Phillips EM, Koser J, Sauder U, Ullman KS, Powers MA, Fahrenkrog B. Nucleoporin domain topology is linked to the transport status of the nuclear pore complex. J Mol Biol. 2005;351:784\u201398.","journal-title":"J Mol Biol"},{"key":"262_CR69","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1742-4690-8-38","volume":"8","author":"F Diaz-Griffero","year":"2011","unstructured":"Diaz-Griffero F, Gallo DE, Hope TJ, Sodroski J. Trafficking of some old world primate TRIM5alpha proteins through the nucleus. Retrovirology. 2011;8:38.","journal-title":"Retrovirology"},{"key":"262_CR70","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature12769","volume":"503","author":"J Rasaiyaah","year":"2013","unstructured":"Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature. 2013;503:402\u20135.","journal-title":"Nature"},{"key":"262_CR71","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1038\/emboj.2012.251","volume":"31","author":"T Naganuma","year":"2012","unstructured":"Naganuma T, Nakagawa S, Tanigawa A, Sasaki YF, Goshima N, Hirose T. Alternative 3\u2032-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012;31:4020\u201334.","journal-title":"EMBO J"},{"key":"262_CR72","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/pro.2456","volume":"23","author":"SM Lambert","year":"2014","unstructured":"Lambert SM, Langley DR, Garnett JA, Angell R, Hedgethorne K, Meanwell NA, Matthews SJ. The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors. Protein Sci Publ Protein Soc. 2014;23:723\u201334.","journal-title":"Protein Sci Publ Protein Soc"},{"key":"262_CR73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virusres.2012.09.012","volume":"170","author":"A Fassati","year":"2012","unstructured":"Fassati A. Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res. 2012;170:15\u201324.","journal-title":"Virus Res"},{"key":"262_CR74","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1128\/JVI.00616-07","volume":"81","author":"T Schaller","year":"2007","unstructured":"Schaller T, Ylinen LM, Webb BL, Singh S, Towers GJ. Fusion of cyclophilin A to Fv1 enables cyclosporine-sensitive restriction of human and feline immunodeficiency viruses. J Virol. 2007;81:10055\u201363.","journal-title":"J Virol"},{"key":"262_CR75","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1128\/JVI.80.8.4061-4067.2006","volume":"80","author":"MW Yap","year":"2006","unstructured":"Yap MW, Dodding MP, Stoye JP. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. J Virol. 2006;80:4061\u20137.","journal-title":"J Virol"},{"key":"262_CR76","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.1128\/JVI.00325-11","volume":"85","author":"KA Matreyek","year":"2011","unstructured":"Matreyek KA, Engelman A. The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid. J Virol. 2011;85:7818\u201327.","journal-title":"J Virol"},{"key":"262_CR77","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1128\/JVI.75.8.3626-3635.2001","volume":"75","author":"A Fassati","year":"2001","unstructured":"Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J Virol. 2001;75:3626\u201335.","journal-title":"J Virol"},{"key":"262_CR78","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.virol.2014.02.004","volume":"454\u2013455","author":"Z Ambrose","year":"2014","unstructured":"Ambrose Z, Aiken C. HIV-1 uncoating: connection to nuclear entry and regulation by host proteins. Virology. 2014;454\u2013455:371\u20139.","journal-title":"Virology"},{"key":"262_CR79","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nnano.2014.262","volume":"10","author":"A Bestembayeva","year":"2015","unstructured":"Bestembayeva A, Kramer A, Labokha AA, Osmanovic D, Liashkovich I, Orlova EV, Ford IJ, Charras G, Fassati A, Hoogenboom BW. Nanoscale stiffness topography reveals structure and mechanics of the transport barrier in intact nuclear pore complexes. Nat Nanotechnol. 2015;10:60\u20134.","journal-title":"Nat Nanotechnol"},{"key":"262_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature14226","volume":"521","author":"B Marini","year":"2015","unstructured":"Marini B, Kertesz-Farkas A, Ali H, Lucic B, Lisek K, Manganaro L, Pongor S, Luzzati R, Recchia A, Mavilio F, Giacca M, Lusic M. Nuclear architecture dictates HIV-1 integration site selection. Nature. 2015;521:227\u201331.","journal-title":"Nature"},{"key":"262_CR81","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1038\/ncomms7483","volume":"6","author":"M Lelek","year":"2015","unstructured":"Lelek M, Casartelli N, Pellin D, Rizzi E, Souque P, Severgnini M, Di Serio C, Fricke T, Diaz-Griffero F, Zimmer C, Charneau P, Di Nunzio F. Chromatin organization at the nuclear pore favours HIV replication. Nat Commun. 2015;6:6483.","journal-title":"Nat Commun"},{"key":"262_CR82","doi-asserted-by":"publisher","first-page":"e1003461","DOI":"10.1371\/journal.ppat.1003461","volume":"9","author":"SJ Rihn","year":"2013","unstructured":"Rihn SJ, Wilson SJ, Loman NJ, Alim M, Bakker SE, Bhella D, Gifford RJ, Rixon FJ, Bieniasz PD. Extreme genetic fragility of the HIV-1 capsid. PLoS Pathog. 2013;9:e1003461.","journal-title":"PLoS Pathog"},{"key":"262_CR83","unstructured":"Chemical Computing Group, Molecular Operating Environment (MOE) 2014.09 2014, Chemical Computing Group Inc. 1010 Sherbooke St. West, Suite 910."},{"key":"262_CR84","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2009.04.063","volume":"137","author":"O Pornillos","year":"2009","unstructured":"Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell. 2009;137:1282\u201392.","journal-title":"Cell"},{"key":"262_CR85","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1747-0285.2010.00956.x","volume":"75","author":"B Loh","year":"2010","unstructured":"Loh B, Vozzolo L, Mok BJ, Lee CC, Fitzmaurice RJ, Caddick S, Fassati A. Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides. Chem Biol Drug Des. 2010;75:461\u201374.","journal-title":"Chem Biol Drug Des"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-016-0262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-016-0262-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-016-0262-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-016-0262-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:37:58Z","timestamp":1589535478000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-016-0262-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,23]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s12977-016-0262-0","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,23]]},"assertion":[{"value":"15 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"28"}}